To evaluate the safety and efficacy of higher fluence cornea collagen cross linking (CXL). Methods: Twenty-one patients with bilateral keratoconus had randomized CXL in one eye (group A) with 7 mw/cm 2 for 15 minutes; the other eye (group B) had the standard 3 mw/cm 2 for 30 minutes; 50 um PTK with the Eye-Q 400 Hz Excimer laser (Wavelight, Erlagen, G ermany) was used for epithelial removal. The patients were evaluated postoperatively at the following intervals: day 1, day 4, month 1, month 3, and then every 6 months.
Introduction
The management of keratoconus (KCN) with collagen cross linking (CXL), utilizing UV irradiation and simultaneous topical riboflavin administration, has been studied at length. This has taken place both in laboratory work as well as clinical work, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and received the CE mark of approval, in December 2006, for clinical use in countries in the European Union. The standard technique described by Wollensak et al involves partial or complete central epithelial removal, followed by topical administration of riboflavin 0.1% solution in order to achieve intra-stromal penetration. We theorized that by increasing the UV light fluence we targeted the following: (1) a faster procedure, as the fluence time is shortened, and (2) shorter keratocyte exposure time and potentially less fibrocyte cornea damage caused.
Methods
Twenty-one patients with bilateral progressive keratoconus were studied. The study is a prospective randomized comparative case series. These patients were selected with the following criteria: 
Surgical technique
Phototherapeutic keratectomy (PTK) epithelial removal: under topical 1% proparacaine anesthesia (Alcaine, Alcon, Fort Worth, Texas), the Wavelight 400 Hz Excimer laser was used for PTK with the parameters of 6.5 mm optical zone, 50 um depth of tissue removal. This mode was used instead of manual epithelial removal for several reasons: (1) to avoid ethanol-related cornea toxicity, and (2) to use the epithelium as a masking agent in epithelial removal, anticipating that this mode would perhaps remove Bowman's membrane and possibly some stroma over the area of the cone, as the epithelium there is usually significantly thinner. Collagen cross-linking: 0.1 ml of 0.1% of riboflavin solution was administered every 30 seconds for 5 minutes (10 drops) until the de-epithelialized cornea was a bright yellow color, due to the presence and stromal infiltration of the riboflavin solution. The preceding removal of Bowman's membrane at the cone area facilitated rapid riboflavin solution diffusion within the stroma within 5 minutes. The cornea was then exposed to UV light: group A with 7 mW/cm 2 for 15 minutes and group B for the standard 3 mW/cm 2 for 30 minutes. A UV irradiation source of an average 370 nm wavelength (365-375 nm) was used to irradiate the corneal surface. The effective fluence at the corneal surface was calibrated at 7 mW/cm 2 and lasted 15 minutes. The total amount of UV irradiation d elivered at an 8 mm-diameter corneal plane was calculated to be 6.3 joules (in comparison to 5.4 joules for group B).
Post-op medicines included topical ofloxacin four times daily for 1 week, and a combination of chlorampenicol and 1% prednisolone acetate (Dispersadron C, Alcon) four times daily for a month and twice daily for another month. Vitamin C -1000 mg per day -was administered orally for 2 months, and patients were encouraged to avoid direct sunlight. The patients were evaluated at postoperative day 1, day 4, month 1, month 3, and then every 6 months.
results Table 1 There was an initial reduction of cornea pachymetry at 1 month, at about 20% of the preoperative pachymetry m easurement. The mean thinnest cornea pachymetry appeared to increase at 18 months follow-up by 25%, on average, when compared to postoperatives in the first month, and by 5% when compared to the preoperative pachymetry measurement. All patients returned to full activities postoperatively within a month. Four cases from group A and five cases from group B had delayed epithelial healing (completed in day nine). No other adverse effects were noted in any of the cases studied. Mean follow-up was 46 months .
Representative pre-and postoperative tomographies for two eyes from group A, along with their topographic d ifference, are displayed in Figures 1 and 2 . Slit lamp biomicroscopy revealed no long term epithelial defects, and diffuse light scattering in anterior 2/3 of the cornea stroma, consistent with our clinical findings from the standard CXL technique, was more intense and much broader in diameter in group A (Figures 3 and 4) .
Discussion
We have clinically applied CXL, utilizing ultraviolet A irradiation and riboflavin solution in cornea ectasia, keratoconus and bullous keratopathy over the last 6 years. [12] [13] [14] [15] [16] [18] [19] [20] [21] [22] [23] [24] We have previously presented and reported the employment of higher fluence CXL with riboflavin submit your manuscript | www.dovepress.com Dovepress Dovepress solution administration via a femtosecond created intracorneal pocket. 22 CXL was shown to have a documented benefit to corneal ectatic disorders. One of the shortcomings with the standard Dresden protocol are lengthy exposure duration (30 minutes). Post-operative pain, delayed epithelial healing, and delayed visual rehabilitation for 1 to 2 weeks postoperatively are some of the other shortcomings.
The contributing elements in the CXL photo-oxidative and biochemical reactions are riboflavin, UVA light, oxygen, and stromal collagen. There is a potential limit of oxygen availability and absorption by riboflavin within the stroma during the length of standard cross-linking procedure. If the riboflavin was already present in the cornea stroma, a larger portion of UVA light may pass through the cornea epithelium and produce the photochemical reaction in the cornea stroma instead of the eye's surface, therefore facilitating more efficient intra-stromal cross-linking and potentially less collateral toxicity to the cornea surface.
In the standard technique, the riboflavin-soaked cornea stroma absorbs the UVA light and, with oxygen, produces a photo-oxidative reaction (type 2). The product is a free radical oxygen molecule, which facilitates a biochemical reaction within stromal collagen. We speculate that it generates fiber to fiber bonds, or bonds between proteoglycans and collagen fibrils, 25 leading to higher stromal rigidity.
The novel method described herein, where higher fluence UV light is used with shorter exposure, appears to be safe and effective in stabilizing keratoconus. 
